BSE Live
Dec 31, 16:01Prev. Close
388.45
Open Price
388.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:59Prev. Close
386.55
Open Price
388.00
Bid Price (Qty.)
376.30 (1480)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Panacea Biotec (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | |
| Total Share Capital | 22.43 | 6.13 | 6.13 | 6.13 | 6.13 | |
| Reserves and Surplus | 517.28 | 556.16 | 555.13 | 805.91 | 630.68 | |
| Total Reserves and Surplus | 517.28 | 556.16 | 555.13 | 805.91 | 630.68 | |
| Total Shareholders Funds | 539.71 | 562.29 | 561.26 | 812.04 | 636.81 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 628.44 | 480.12 | 607.20 | 483.03 | 423.72 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 20.50 | 75.66 | |
| Other Long Term Liabilities | 0.70 | 1.73 | 2.36 | 0.00 | 0.00 | |
| Long Term Provisions | 11.68 | 2.02 | 2.52 | 2.06 | 2.36 | |
| Total Non-Current Liabilities | 640.82 | 483.87 | 612.08 | 505.59 | 501.74 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 319.83 | 354.41 | 299.14 | 269.34 | 382.44 | |
| Trade Payables | 186.97 | 226.26 | 153.99 | 118.14 | 82.69 | |
| Other Current Liabilities | 186.75 | 248.12 | 43.47 | 136.36 | 101.00 | |
| Short Term Provisions | 5.15 | 11.51 | 9.88 | 9.36 | 13.11 | |
| Total Current Liabilities | 698.70 | 840.30 | 506.48 | 533.20 | 579.24 | |
| Total Capital And Liabilities | 1,879.23 | 1,886.46 | 1,679.82 | 1,852.88 | 1,717.79 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,039.79 | 1,055.09 | 916.98 | 954.34 | 534.63 | |
| Intangible Assets | 19.89 | 30.86 | 41.86 | 46.97 | 12.45 | |
| Capital Work-In-Progress | 4.69 | 13.72 | 16.94 | 12.07 | 22.94 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 1,076.66 | 1,112.03 | 986.41 | 1,048.37 | 652.36 | |
| Non-Current Investments | 394.66 | 394.20 | 265.35 | 258.47 | 232.94 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 92.68 | 80.76 | 102.68 | 82.17 | 104.65 | |
| Other Non-Current Assets | 0.06 | 0.18 | 0.00 | 0.12 | 0.09 | |
| Total Non-Current Assets | 1,564.06 | 1,587.17 | 1,354.44 | 1,389.13 | 990.04 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 140.90 | 176.76 | 224.74 | 339.73 | 368.02 | |
| Trade Receivables | 100.43 | 90.58 | 68.75 | 66.45 | 278.84 | |
| Cash And Cash Equivalents | 42.37 | 9.68 | 12.59 | 11.33 | 39.38 | |
| Short Term Loans And Advances | 26.42 | 18.38 | 16.35 | 41.17 | 33.48 | |
| OtherCurrentAssets | 5.05 | 3.89 | 2.95 | 5.07 | 8.03 | |
| Total Current Assets | 315.17 | 299.29 | 325.38 | 463.75 | 727.75 | |
| Total Assets | 1,879.23 | 1,886.46 | 1,679.82 | 1,852.88 | 1,717.79 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 135.16 | 49.01 | 31.09 | 218.40 | 283.99 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.72 | 3.47 | 7.43 | 22.69 | 9.12 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 27.40 | 41.72 | 56.87 | 63.36 | 46.37 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | 0.07 | 0.03 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 212.51 | 126.38 | 90.52 | 343.65 | 710.39 | |
| Other Earnings | 27.38 | 27.54 | 30.15 | 3.67 | 4.20 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 1.81 | 1.81 | 1.81 | 1.81 | 1.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 394.66 | 394.20 | 271.85 | 258.47 | 249.99 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y